Your browser doesn't support javascript.
loading
Clinical Practice Guideline for Red Blood Cell Transfusion Thresholds in Very Preterm Neonates.
Deschmann, Emöke; Dame, Christof; Sola-Visner, Martha C; Fustolo-Gunnink, Susanna F; Guyatt, Gordon H; Patel, Ravi Mangal; Stanworth, Simon J.
Afiliación
  • Deschmann E; Department of Neonatology, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden.
  • Dame C; Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Sola-Visner MC; Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Fustolo-Gunnink SF; Sanquin Blood Supply Foundation, Amsterdam, the Netherlands.
  • Guyatt GH; Amsterdam University Medical Center, Amsterdam, the Netherlands.
  • Patel RM; Leiden University Medical Center, Leiden, the Netherlands.
  • Stanworth SJ; McMaster University, Toronto, Ontario, Canada.
JAMA Netw Open ; 7(6): e2417431, 2024 Jun 03.
Article en En | MEDLINE | ID: mdl-38874929
ABSTRACT
Importance Red blood cell (RBC) transfusion is a common medical intervention to treat anemia in very preterm neonates; however, best transfusion practices, such as thresholds, remain uncertain.

Objective:

To develop recommendations for clinicians on the use of RBC transfusions in very preterm neonates. Evidence Review An international steering committee reviewed evidence from a systematic review of 6 randomized clinical trials (RCTs) that compared high vs low hemoglobin-based or hematocrit-based transfusion thresholds. The steering committee reached consensus on certainty-of-evidence ratings and worked with a panel from stakeholder organizations on reviewing the evidence. With input from parent representatives and the stakeholder panel, the steering committee used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach to develop recommendations.

Findings:

A systematic review of 6 RCTs encompassing 3483 participants (1759 females [51.3%]; mean [SD] age range, 25.9-29.8 [1.5-3.0] weeks) was used as the basis of the recommendations. The ranges for higher hemoglobin concentration (liberal) vs lower hemoglobin concentration (restrictive) threshold study arms were similar across the trials. However, specific thresholds differed based on the severity of illness, which was defined using variable criteria in the trials. There was moderate certainty of evidence that low transfusion thresholds likely had little to no difference in important short-term and long-term outcomes. The recommended hemoglobin thresholds varied on the basis of postnatal week and respiratory support needs. At postnatal weeks 1, 2, and 3 or more, for neonates on respiratory support, the recommended thresholds were 11, 10, and 9 g/dL, respectively; for neonates on no or minimal respiratory support, the recommended thresholds were 10, 8.5, and 7 g/dL, respectively (to convert hemoglobin to grams per liter, multiply by 10.0). Conclusions and Relevance This consensus statement recommends a restrictive RBC transfusion strategy, with moderate certainty of evidence, for preterm neonates with less than 30 weeks' gestation.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transfusión de Eritrocitos Límite: Female / Humans / Male / Newborn Idioma: En Revista: JAMA Netw Open Año: 2024 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transfusión de Eritrocitos Límite: Female / Humans / Male / Newborn Idioma: En Revista: JAMA Netw Open Año: 2024 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Estados Unidos